T. Rowe Price Investment Management Inc. Increases Position in Mettler-Toledo International, Inc. $MTD

T. Rowe Price Investment Management Inc. boosted its position in Mettler-Toledo International, Inc. (NYSE:MTDFree Report) by 0.5% during the fourth quarter, Holdings Channel reports. The fund owned 691,565 shares of the medical instruments supplier’s stock after acquiring an additional 3,157 shares during the period. T. Rowe Price Investment Management Inc.’s holdings in Mettler-Toledo International were worth $964,174,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in MTD. Nordea Investment Management AB grew its holdings in shares of Mettler-Toledo International by 11.9% during the 4th quarter. Nordea Investment Management AB now owns 157,457 shares of the medical instruments supplier’s stock valued at $220,718,000 after purchasing an additional 16,777 shares during the last quarter. Citigroup Inc. lifted its stake in Mettler-Toledo International by 4.8% in the third quarter. Citigroup Inc. now owns 65,033 shares of the medical instruments supplier’s stock worth $79,835,000 after purchasing an additional 2,989 shares during the last quarter. Pensionfund Sabic purchased a new stake in Mettler-Toledo International during the fourth quarter valued at about $1,255,000. M&T Bank Corp grew its stake in shares of Mettler-Toledo International by 2,813.6% during the fourth quarter. M&T Bank Corp now owns 124,205 shares of the medical instruments supplier’s stock valued at $173,165,000 after buying an additional 119,942 shares during the last quarter. Finally, Crossmark Global Holdings Inc. grew its stake in shares of Mettler-Toledo International by 34.3% during the fourth quarter. Crossmark Global Holdings Inc. now owns 4,150 shares of the medical instruments supplier’s stock valued at $5,786,000 after buying an additional 1,060 shares during the last quarter. Hedge funds and other institutional investors own 95.07% of the company’s stock.

Analyst Upgrades and Downgrades

MTD has been the subject of a number of recent research reports. Robert W. Baird lowered their target price on Mettler-Toledo International from $1,445.00 to $1,194.00 and set a “neutral” rating for the company in a research note on Monday, May 11th. JPMorgan Chase & Co. reduced their price target on Mettler-Toledo International from $1,413.00 to $1,200.00 and set a “neutral” rating on the stock in a research report on Monday, May 11th. Wolfe Research began coverage on Mettler-Toledo International in a research note on Tuesday, June 2nd. They issued a “peer perform” rating on the stock. Jefferies Financial Group upgraded Mettler-Toledo International from a “hold” rating to a “buy” rating and boosted their price objective for the company from $1,400.00 to $1,450.00 in a research report on Friday, March 20th. Finally, Barclays dropped their price objective on Mettler-Toledo International from $1,550.00 to $1,500.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Six investment analysts have rated the stock with a Buy rating and seven have given a Hold rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $1,408.55.

Check Out Our Latest Research Report on MTD

Mettler-Toledo International Trading Up 1.4%

Shares of NYSE:MTD opened at $1,145.08 on Friday. The company has a market cap of $23.14 billion, a price-to-earnings ratio of 26.85, a price-to-earnings-growth ratio of 2.36 and a beta of 1.27. The company has a 50-day moving average price of $1,194.36 and a 200-day moving average price of $1,302.95. Mettler-Toledo International, Inc. has a 12 month low of $1,023.05 and a 12 month high of $1,525.17.

Mettler-Toledo International (NYSE:MTDGet Free Report) last posted its earnings results on Thursday, May 7th. The medical instruments supplier reported $8.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $8.70 by $0.21. Mettler-Toledo International had a negative return on equity of 622.80% and a net margin of 21.40%.The company had revenue of $947.13 million for the quarter, compared to analysts’ expectations of $943.14 million. During the same period last year, the firm earned $8.19 earnings per share. Mettler-Toledo International’s quarterly revenue was up 7.2% on a year-over-year basis. Mettler-Toledo International has set its FY 2026 guidance at 46.300-46.950 EPS and its Q2 2026 guidance at 10.700-10.850 EPS. As a group, research analysts forecast that Mettler-Toledo International, Inc. will post 46.6 EPS for the current fiscal year.

Mettler-Toledo International Profile

(Free Report)

Mettler-Toledo International Inc is a global manufacturer and distributor of precision instruments and services for laboratory, industrial and food retail applications. The company’s product portfolio includes laboratory balances and analytical instruments, industrial weighing systems, process analytics and sensors, metal detection and x-ray inspection equipment, checkweighers, and a range of automated inspection and data-management solutions. Mettler-Toledo also provides software, calibration and lifecycle services intended to support compliance, quality control and operational efficiency across customer facilities.

The company serves a broad set of end markets including pharmaceutical and biotech laboratories, chemical and food processors, logistics and manufacturing operations, and retail environments where accurate weighing and inspection are critical.

Recommended Stories

Want to see what other hedge funds are holding MTD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Mettler-Toledo International, Inc. (NYSE:MTDFree Report).

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.